Showing 1011-1020 of 2869 results for "".
MATV News: Restylane Lyft for Hands; Positive Results for ThermiVa; Rosacea Burden
https://modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-for-hands-positive-results-for-thermiva-rosacea-burden/33270/Restylane Lyft is now approved to fill the dorsal hands, #WeAllGrow Latina Network in favor of body contouring procedures, a new study on ThermiVa shows positive results, and Galderma shares results of global survey on rosacea showing need for physicians to open a dialogue with patients suffering frFix These Website Flaws Now
https://modernaesthetics.com/ma-issues-index/2018-may-june/fix-these-website-flaws-now/34113/Simple coding errors may be sabotaging your rankings.MATV News: New ASAPS Leadership; Evaluating PRP; Improving Patient Follow Up; Silhouette Instalift Relaunch
https://modernaesthetics.com/series/matv-news/matv-news-new-asaps-leadership-evaluating-prp-improving-patient-follow-up-silhouette-instalift-relaunch/33273/The American Society for Aesthetic Plastic Surgery and the Aesthetic Surgery Education and Research Foundation name new presidents, researchers review studies on the safety and efficacy of platelet-rich plasma injection for facial rejuvenation and other cosmetic procedures, and eRelevance offers a nVASER: Targeting Fat; Redefining Success
https://modernaesthetics.com/ma-supplements/2018-mar-apr-supplement/vaser-targeting-fat-redefining-success/34168/A safe and versatile system, VASER is reshaping the approach to fat reduction and body contouring.MATV News: Hair Restoration Procedures on the Rise; FDA Approvals; New Digital Marketing Book
https://modernaesthetics.com/series/matv-news/matv-news-hair-restoration-procedures-on-the-rise-fda-approvals-new-digital-marketing-book/33312/The latest statistics from the ISHRS show hair restoration procedures are on the rise, Galderma's Restylane Silk is now approved for injection via cannula, and the FDA cleared Solta's new Thermage FLX. Plus, a look at a new book by marketing expert Wendy Lewis on best practices for social media andMATV News: Valeant Sells Obagi; Aesthetic Trends Around the Globe
https://modernaesthetics.com/series/matv-news/matv-news-valeant-sells-obagi-aesthetic-trends-around-the-globe/33323/Valeant agrees to sell its Obagi Medical Products business, Syneron Candela is now a private company, and Allergan acquired the Reginica Advanced Rejuvenation System line. Also, coverage of the latest trends in aesthetics, according to new statistics from the International Society of Aesthetic PlastMATV News: Men and Aesthetic Surgery; Smartphones in Practice; VCS Update
https://modernaesthetics.com/series/matv-news/matv-news-men-and-aesthetic-surgery-smartphones-in-practice-vcs-update/33336/Aesthetic surgery is increasingly becoming a guy thing, smartphones may play an important role in post-treatment care, and a look at how memory age affects patients' perceptions of themselves. Also, coverage of the recent Vegas Cosmetic Surgery 2017 meeting. And, we want to hear from about if you usMATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aWhen I Grow Up
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/when-i-grow-up/34311/Exploring opportunities beyond traditional patient care. Pros and cons from those on the front-line.MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus Velocity